HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasushi Honda Selected Research

Fibrosis (Cirrhosis)

2/2024Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma.
11/2023Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH.
11/2023Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease.
12/2022Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD.
10/2022Comparison of long-term prognosis between non-obese and obese patients with non-alcoholic fatty liver disease.
7/2021The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target.
3/2021Vitamin B6 efficacy in the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, single-center trial.
10/2020Advances in ultrasound elastography for nonalcoholic fatty liver disease.
7/2020Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?
10/2018Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasushi Honda Research Topics

Disease

37Non-alcoholic Fatty Liver Disease
11/2023 - 01/2014
15Fibrosis (Cirrhosis)
02/2024 - 08/2015
12Liver Cirrhosis (Hepatic Cirrhosis)
11/2023 - 01/2018
9Inflammation (Inflammations)
11/2023 - 01/2016
8Hyperventilation
01/2019 - 02/2006
7Neoplasms (Cancer)
04/2022 - 08/2006
6Liver Diseases (Liver Disease)
11/2023 - 01/2017
5Insulin Resistance
11/2023 - 01/2016
5Constipation
10/2021 - 01/2017
3Obesity
10/2021 - 01/2016
3Dysbiosis
07/2021 - 01/2018
2Fatty Liver
11/2023 - 01/2023
2Opioid-Induced Constipation
04/2022 - 06/2020
2Body Weight (Weight, Body)
01/2022 - 01/2021
2Hyperemia
11/2021 - 01/2020
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 03/2020
2Hyperthermia
12/2019 - 01/2018
2Delirium
05/2019 - 03/2018
2Alcoholic Fatty Liver
01/2019 - 01/2014
2Mouth Neoplasms (Oral Cancer)
03/2018 - 03/2018
2Pain (Aches)
03/2018 - 03/2018
2Mucositis
03/2018 - 03/2018
2Poisoning
08/2017 - 01/2014
1Cadaver (Cadavers)
11/2023
1Diarrhea
11/2023
1Carcinogenesis
11/2023
1Atherosclerosis
11/2023
1Heat Stroke (Heatstroke)
09/2023
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2023
1Overweight
12/2022
1Hypertension (High Blood Pressure)
12/2022
1Drowning
01/2022
1Diabetes Mellitus
01/2022
1Weight Gain
01/2022

Drug/Important Bio-Agent (IBA)

7Protons (Proton)IBA
12/2022 - 01/2020
6Alanine Transaminase (SGPT)IBA
11/2023 - 03/2016
5LipidsIBA
11/2023 - 01/2014
5Collagen Type IV (Type IV Collagen)IBA
03/2023 - 12/2017
4Opioid Analgesics (Opioids)IBA
04/2022 - 03/2018
4EndotoxinsIBA
07/2021 - 01/2018
4LubiprostoneFDA Link
07/2021 - 01/2017
3CholesterolIBA
11/2023 - 01/2020
3elobixibatIBA
11/2023 - 01/2020
3Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2019
36- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA
01/2022 - 03/2020
3Pioglitazone (Actos)FDA Link
01/2022 - 03/2020
3Therapeutic UsesIBA
03/2021 - 01/2016
2Proteins (Proteins, Gene)FDA Link
02/2024 - 10/2018
2RNA (Ribonucleic Acid)IBA
11/2023 - 12/2017
2Cholestyramine Resin (Questran)FDA LinkGeneric
11/2023 - 01/2020
2Bile Acids and Salts (Bile Acids)IBA
11/2023 - 01/2022
2Air Pollutants (Pollutants, Air)IBA
01/2023 - 01/2016
2Fatty Acids (Saturated Fatty Acids)IBA
12/2022 - 01/2018
2Ferritins (Ferritin)IBA
10/2022 - 06/2015
2Magnesium Oxide (Magnesia)FDA Link
04/2022 - 06/2020
2naldemedineIBA
04/2022 - 06/2020
2Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2022 - 07/2021
2Indicators and Reagents (Reagents)IBA
01/2022 - 01/2014
2Nitric Oxide Synthase (NO Synthase)IBA
11/2021 - 01/2020
2Messenger RNA (mRNA)IBA
10/2021 - 08/2015
2Sodium-Glucose Transport ProteinsIBA
01/2021 - 07/2020
2Sodium-Glucose Transporter 2 InhibitorsIBA
07/2020 - 01/2016
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2020 - 01/2017
2oxidized low density lipoproteinIBA
01/2020 - 01/2014
2Fentanyl (Sublimaze)FDA LinkGeneric
03/2018 - 03/2018
2Nonesterified Fatty Acids (NEFA)IBA
01/2018 - 01/2016
2Oxygen (Dioxygen)IBA
09/2015 - 11/2010
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
11/2023
1Triglycerides (Triacylglycerol)IBA
11/2023
1Small Interfering RNA (siRNA)IBA
11/2023
1Sterol Regulatory Element Binding Protein 1IBA
11/2023
1ApolipoproteinsIBA
11/2023
1FructoseIBA
11/2023
1Greenhouse GasesIBA
09/2023
1Oxidants (Oxidizing Agents)IBA
01/2023
1Particulate MatterIBA
01/2023
1Sulfur DioxideIBA
01/2023
1Nitrogen DioxideIBA
01/2023
1Guanabenz (BR 750)FDA Link
12/2022
1CreatinineIBA
10/2022
1BilirubinIBA
10/2022
1HDL LipoproteinsIBA
10/2022
1Chenodeoxycholic Acid (Chenix)FDA Link
01/2022
1IronIBA
01/2022
1Capsules (Microcapsules)IBA
01/2022
1methyl methanethiosulfonate (MMTS)IBA
01/2022
1Adenosine Triphosphatases (ATPase)IBA
11/2021
1SGL5213IBA
10/2021
1bile acid binding proteinsIBA
10/2021
1GlucosidasesIBA
10/2021
1Glucose (Dextrose)FDA LinkGeneric
10/2021
1miglitol (Glyset)FDA Link
10/2021
1Sucrose (Saccharose)IBA
10/2021
1Sodium-Glucose Transporter 1IBA
10/2021

Therapy/Procedure

10Therapeutics
04/2022 - 06/2015
7Induced Hyperthermia (Thermotherapy)
01/2019 - 11/2009
3Oral Administration
12/2022 - 08/2017
3Liver Transplantation
09/2021 - 07/2020
2Palliative Care (Palliative Therapy)
10/2021 - 03/2018
2Drug Therapy (Chemotherapy)
01/2019 - 03/2018